Breaking Down the FDA's 2022 Guidance on Diversity
Fill form to unlock content
Error - something went wrong!
Fill out this form to access your content
Learn from our Chief Clinical Trial Officer and former Director of Clinical Research Administration at the Vanderbilt-Ingram Cancer Center, Catherine Gregor, about the newly published FDA draft guidance for increasing participant enrollment from underrepresented racial and ethnic groups in clinical trials.